Document Detail


Functional imaging of renal cell carcinoma.
MedLine Citation:
PMID:  20448659     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The incidence of early and advanced-stage renal cell carcinoma (RCC) is increasing. Methods of diagnosing, staging and evaluating tumor burden that are more accurate and reliable than the currently available options are needed in order to identify RCC at a stage at which it is curable and to accurately determine the response to treatment. Functional imaging, particularly with combined PET-CT, might improve accuracy of detection and provide essential information that has been unavailable to date. This approach is against a background in which targeted therapies for metastatic RCC have entered clinical practice in the past few years, further highlighting the importance of accurate imaging for patient selection and for monitoring response to treatment. We outline the current clinical status of functional imaging in RCC using PET-CT, which allows simultaneous capture and co-registration of functional and anatomical data. New radiotracers and approaches-including radiolabeled monoclonal antibodies and imaging of tumor hypoxia-are touched on, and areas of future research discussed.
Authors:
Nathan Lawrentschuk; Ian D Davis; Damien M Bolton; Andrew M Scott
Related Documents :
16925579 - Staging performance of carbon-11 choline positron emission tomography/computed tomograp...
17098649 - Detection, staging and surveillance in renal cell carcinoma.
11214619 - Correlations of serum ca125 level and computerized tomography (ct) imaging with laparot...
20305419 - Subcutaneous metastases of colorectal cancer detected with pet/ct.
15299049 - Retrospective digital image fusion of multidetector ct and 18f-fdg pet: clinical value ...
18183409 - A case of pathologic fracture of femur whose primary tumor and occult metastases were a...
10598059 - Cerebral fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (fdg ...
16012299 - Diagnostic value of multislice computed tomography for pancreas divisum: assessment wit...
7753989 - Bronchiectasis: comparison of preoperative thin-section ct and pathologic findings in r...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Nature reviews. Urology     Volume:  7     ISSN:  1759-4820     ISO Abbreviation:  Nat Rev Urol     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-05-07     Completed Date:  2010-08-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101500082     Medline TA:  Nat Rev Urol     Country:  England    
Other Details:
Languages:  eng     Pagination:  258-66     Citation Subset:  IM    
Affiliation:
Department of Surgical Oncology, University of Toronto, Princess Margaret Hospital, ON, Canada. nathan.lawrentschuk@uhn.on.ca <nathan.lawrentschuk@uhn.on.ca>
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Carcinoma, Renal Cell / pathology*
Decision Making
Fluorodeoxyglucose F18 / diagnostic use
Humans
Kidney Neoplasms / pathology*
Lymph Nodes / pathology
Neoplasm Metastasis
Neoplasm Staging
Positron-Emission Tomography
Radioimmunodetection
Radiopharmaceuticals / diagnostic use
Tomography, X-Ray Computed
Chemical
Reg. No./Substance:
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Epidemiology and risk factors for kidney cancer.
Next Document:  Long-term management of bilateral, multifocal, recurrent renal carcinoma.